Recent Posts

New Jersey High Court: Some Warning, Warranty Claims About Stent Aren't Preempted
Posted on 10 Aug 2012 by Tom Moylan

TRENTON, N.J. - (Mealey's) The New Jersey Supreme Court on Aug. 9 ruled that some failure-to-warn claims and some breach of warranty claims involving the Cordis Cypher drug-coated coronary stent may survive federal preemption, a ruling that applies... Read More

Boston Scientific Securities Fraud Class Action Dismissed
Posted on 28 Apr 2010 by Tom Moylan

BOSTON - (Mealey's) A federal judge in Massachusetts on April 27 dismissed a putative securities class action stemming from Boston Scientific Corp.'s recalled Taxus and Taxus Express2 stents, saying that the market was aware of problems with the... Read More